The valuation of outcomes for the temporary and chronic health states associated with Chlamydia trachomatis infection - Ogwulu, Chidubem B.Okeke; Jackson, Louise J.; Kinghorn, Philip; Roberts, Tracy E. (medRxiv, 2021)
Background Eliciting health-state utility values (HSUVs) for some diseases is complicated by the mix of associated temporary (THSs) and chronic health states (CHSs). This study uses one such disease, chlamydia infection, to explore the challenges. The objectives were to:Define a set of health-state descriptions related to chlamydia andDerive HSUVs for these health states (both temporary and chronic).Methods HSUVs were elicited for seven health states (five THSs and two CHSs) depicting the symptoms of chlamydia, developed using evidence from the literature and clinical experts. The chained time trade-off (TTO) and visual analogue scale (VAS) were applied to THSs while conventional TTO was applied to the CHSs. Ectopic pregnancy was used as the anchor for the chained TTO approach. The study sampled from three different population groups and the survey was administered face-to-face.Results One hundred participants were assessed with an interview completion rate of 100%. Mean TTO utilities were consistently higher than VAS scores. The aggregated mean chained TTO results for the THS ranged from 0.46 (SD, 0.24) for ectopic pregnancy, to 0.77 (SD 0.21) for cervicitis.Conclusions Chained TTO was shown to be feasible in this population and the resulting HSUVs could have implications for economic evaluations for chlamydia prevention and control. Methodological challenges included the development of health-state descriptions, the selection, and the duration of appropriate anchor state.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was conducted as part of a University of Birmingham, College of Medicine and Dental Sciences Studentship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for all University-based participants (Study 1 and Study 3)was obtained from the University of Birmingham Science, Technology, Engineering and Mathematics Ethical Review Committee (ERN_16-1522) Ethical approval for recruitment of Study 2 participants was obtained from the National Health Service (NHS) Health Research Authority (IRAS ID-194331) and the Research Governance Office of the University Hospitals Birmingham NHS Foundation Trust (RRK 6073)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNon applicable